---
schema_version: "secwatch.filing_event.v1"
accession: "0000886163-22-000140"
form_type: "8-K"
ticker: "LGND"
cik: "0000886163"
company_name: "LIGAND PHARMACEUTICALS INC"
filed_at: "2022-12-14T23:59:59+00:00"
generated_at: "2026-06-21T05:06:40.969279+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Ligand increases base salary and target bonus for President/COO and CFO

## Summary
- Matthew Korenberg (President & COO) base salary set at $540,000 with 50% target bonus.
- Octavio Espinoza (CFO) base salary set at $400,000 with 40% target bonus.
- Changes effective December 5, 2022, tied to recent promotions to these roles.

## SEC filing metadata
- accession: 0000886163-22-000140
- form_type: 8-K
- ticker: LGND
- cik: 0000886163
- company_name: LIGAND PHARMACEUTICALS INC
- filed_at: 2022-12-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/886163/000088616322000140/0000886163-22-000140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/886163/000088616322000140/lgnd-20221213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000886163-22-000140
- JSON: https://secwatch.observer/filing/0000886163-22-000140.json
- Plain text: https://secwatch.observer/filing/0000886163-22-000140.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.